A carregar...
C(60) Fullerene as Synergistic Agent in Tumor-Inhibitory Doxorubicin Treatment
BACKGROUND: Doxorubicin (Dox) is one of the most potent anticancer drugs, but its successful use is hampered by high toxicity caused mainly by generation of reactive oxygen species. One approach to protect against Dox-dependent chemical insult is combined use of the cytostatic drug with antioxidants...
Na minha lista:
| Publicado no: | Drugs R D |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer International Publishing
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4269825/ https://ncbi.nlm.nih.gov/pubmed/25504158 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40268-014-0074-4 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|